Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 133,744 |
|
|||||
| News | - | ||||||
| Day High | 0.534 | Low High |
|||||
| Day Low | 0.49 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Traws Pharma Inc | TRAW | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02196 | -4.21% | 0.49914 | 12:50:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.5155 | 0.49 | 0.534 | 0.5211 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 306 | 133,744 | $ 0.513023 | $ 68,614 | - | 0.45 - 0.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:50:36 | 20 | $ 0.495 | USD |
Traws Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.3M | 25.30M | - | 226k | -18.95M | -0.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Traws Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRAW Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.659 | 0.69 | 0.45 | 0.5890073 | 190,655 | -0.15986 | -24.26% |
| 1 Month | 0.633 | 0.71 | 0.45 | 0.6025684 | 115,250 | -0.13386 | -21.15% |
| 3 Months | 0.99 | 0.99 | 0.45 | 0.7064056 | 108,733 | -0.49086 | -49.58% |
| 6 Months | 0.99 | 0.99 | 0.45 | 0.7064056 | 108,733 | -0.49086 | -49.58% |
| 1 Year | 0.99 | 0.99 | 0.45 | 0.7064056 | 108,733 | -0.49086 | -49.58% |
| 3 Years | 0.99 | 0.99 | 0.45 | 0.7064056 | 108,733 | -0.49086 | -49.58% |
| 5 Years | 0.99 | 0.99 | 0.45 | 0.7064056 | 108,733 | -0.49086 | -49.58% |
Traws Pharma Description
| Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. |
